ER stress-induced autophagy in melanoma

被引:27
作者
Meng, Xiao-Xiao [1 ]
Yao, Mu [2 ,3 ]
Zhang, Xu Dong [4 ]
Xu, Hong-Xi [1 ]
Dong, Qihan [2 ,3 ,5 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China
[2] Univ Sydney, Discipline Endocrinol, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia
[3] Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Sydney, NSW 2006, Australia
[4] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia
[5] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia
关键词
autophagy; BRAFi resistant melanoma; ER stress; melanocytic nevus; primary and metastatic melanoma; ENDOPLASMIC-RETICULUM STRESS; RESISTANCE; GENE; MUTATIONS; INHIBITORS; PATHWAY;
D O I
10.1111/1440-1681.12436
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The activation of RAF-MEK-extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase cascade by v-raf murine sarcoma viral oncogene homolog B1 (BRAF)(V600E) mutation is a key alteration in melanoma. Although BRAF inhibitor (BRAFi) has achieved remarkable clinical success, the positive response to BRAFi is not sustainable, and the initial clinical benefit is eventually barred by the development of resistance to BRAFi. There is growing evidence to suggest that endoplasmic reticulum (ER) stress-induced autophagy could be a potential pro-survival mechanism that contributes to genesis of melanoma and to the resistance to BRAFi. ER stress-induced autophagy is an evolutionarily conserved membrane process. By degrading and recycling proteins and organelles via the formation of autophagous vesicles and their fusion with lysosomes, the autophagy plays a key role in homeostasis as well as pathological processes. In this review, we examine the autophagy phenomenon in melanocytic nevus, primary and metastatic melanoma, and its significance in BRAFi-resistant melanoma.
引用
收藏
页码:811 / 816
页数:6
相关论文
共 48 条
  • [1] Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
    Amaravadi, Ravi K.
    Lippincott-Schwartz, Jennifer
    Yin, Xiao-Ming
    Weiss, William A.
    Takebe, Naoko
    Timmer, William
    DiPaola, Robert S.
    Lotze, Michael T.
    White, Eileen
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (04) : 654 - 666
  • [2] The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression
    B'chir, Wafa
    Maurin, Anne-Catherine
    Carraro, Valerie
    Averous, Julien
    Jousse, Celine
    Muranishi, Yuki
    Parry, Laurent
    Stepien, Georges
    Fafournoux, Pierre
    Bruhat, Alain
    [J]. NUCLEIC ACIDS RESEARCH, 2013, 41 (16) : 7683 - 7699
  • [3] Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
    Bertolotti, A
    Zhang, YH
    Hendershot, LM
    Harding, HP
    Ron, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (06) : 326 - 332
  • [4] Emerging insights into resistance to BRAF inhibitors in melanoma
    Bucheit, Amanda D.
    Davies, Michael A.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2014, 87 (03) : 381 - 389
  • [5] BRAFV600E: Implications for Carcinogenesis and Molecular Therapy
    Cantwell-Dorris, Emma R.
    O'Leary, John J.
    Sheils, Orla M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10 (03) : 385 - 394
  • [6] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2507 - 2516
  • [7] Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma
    Corazzari, M.
    Rapino, F.
    Ciccosanti, F.
    Giglio, P.
    Antonioli, M.
    Conti, B.
    Fimia, G. M.
    Lovat, P. E.
    Piacentini, M.
    [J]. CELL DEATH AND DIFFERENTIATION, 2015, 22 (06) : 946 - 958
  • [8] Distinct sets of genetic alterations in melanoma
    Curtin, JA
    Fridlyand, J
    Kageshita, T
    Patel, HN
    Busam, KJ
    Kutzner, H
    Cho, KH
    Aiba, S
    Bröcker, EB
    LeBoit, PE
    Pinkel, D
    Bastian, BC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) : 2135 - 2147
  • [9] Mutations of the BRAF gene in human cancer
    Davies, H
    Bignell, GR
    Cox, C
    Stephens, P
    Edkins, S
    Clegg, S
    Teague, J
    Woffendin, H
    Garnett, MJ
    Bottomley, W
    Davis, N
    Dicks, N
    Ewing, R
    Floyd, Y
    Gray, K
    Hall, S
    Hawes, R
    Hughes, J
    Kosmidou, V
    Menzies, A
    Mould, C
    Parker, A
    Stevens, C
    Watt, S
    Hooper, S
    Wilson, R
    Jayatilake, H
    Gusterson, BA
    Cooper, C
    Shipley, J
    Hargrave, D
    Pritchard-Jones, K
    Maitland, N
    Chenevix-Trench, G
    Riggins, GJ
    Bigner, DD
    Palmieri, G
    Cossu, A
    Flanagan, A
    Nicholson, A
    Ho, JWC
    Leung, SY
    Yuen, ST
    Weber, BL
    Siegler, HF
    Darrow, TL
    Paterson, H
    Marais, R
    Marshall, CJ
    Wooster, R
    [J]. NATURE, 2002, 417 (6892) : 949 - 954
  • [10] The PERK/elF2α/ATF4 module of the UPR in hypoxia resistance and tumor growth
    Fels, Diane R.
    Koumenis, Constantinos
    [J]. CANCER BIOLOGY & THERAPY, 2006, 5 (07) : 723 - 728